Lumida
/CRHM
⌘K
CRHM

CRHM

CRHM
$3.99USD+0.00%+0.00 today

MARKET CAP

0

P/E (TTM)

FWD P/E

DAY RANGE

$4 – $4

52W RANGE

$2
$4

The case for & against

Bull & Bear analysis

Bearish

CRH Medical Corporation, previously traded under the ticker CRHM, was primarily involved in providing anesthesia services and related products to gastroenterology facilities. The business is now a wholly owned subsidiary under WELL Health Technologies Corp. following its acquisition in April 2021. Due to the acquisition, CRH Medical is no longer an independent entity and consequently lacks active trading presence or individual stock sentiment in the market.

Bull says

  • Integrated into WELL Health since April 2021, unlocking cost synergies and resource sharing
  • Gastroenterology anesthesia services address fast-growing outpatient procedure market
  • Access to parent’s capital supports expansion and potential bolt-on acquisitions
  • Operational synergies under WELL Health promise improved profitability margins
  • Broader WELL Health network expands patient base and cross-sell opportunities
  • Enhanced service portfolio under WELL Health drives long-term revenue growth

Bear says

  • Execution challenges in integration may cause service disruptions
  • CRH’s fate tied to WELL Health’s strategic priorities, risking misalignment
  • Regulatory and reimbursement shifts in outpatient care could pressure revenues
  • Loss of independent listing reduces liquidity and stock interest
  • Emerging anesthesiology competitors and tech disruptors threaten market share
  • No standalone financial reporting obscures visibility on performance